Genetic variation of TGF-ΒR2 as a protective genotype for the development of colorectal cancer in men

Figure 2 Transforming growth factor beta serum levels in colorectal cancer patients and healthy controls above 50 years. A: Depending on the TGF-ΒR2 -875G/A genotype; B: Depending on the female CRC patients and controls; C: Depending on the male CRC patients and controls. Results are presented as median and interquartile range. ^aP < 0.05, ^bP < 0.001, ◦outliers.